Baseline surface expression of CD11b, CD62L, and CD66b in Gc in addition to CD11b and CD62 in Mc of healthy, obese, and T2D subjects during glucose, lipids, and glucose + lipids infusions. This evidence concerns the gene SELL and type 2 diabetes mellitus.